Adverse Events

A doctor with a graphic representation of the lungs
Biotech

Pliant ends lung disease program over rise in adverse events

Pliant has terminated its IPF program after digging into the increased rate of adverse events from a 2b/3 trial of its lead candidate bexotegrast.
James Waldron Jun 30, 2025 4:49am
positive negative up down good bad mixed

Amgen's ph. 3 MariTide studies will ramp up dosing to quell nausea

Jun 24, 2025 9:59am
rainbow kite flying in the sky

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm
liver

Intellia stock sinks on gene therapy patient's raised enzymes

May 29, 2025 9:15am
cancelled flights

Pliant terminates lung disease trial due to adverse events

Mar 3, 2025 11:30am
ship board dock container ship tug boat join water

Cargo offloads CAR-T, 50% of staff over efficacy, side effects

Jan 30, 2025 8:05am